According to Gram Research analysis, a nationwide study of 446,237 cancer deaths across Chile found that people living in provinces with lower vitamin D levels had significantly higher death rates from multiple cancers, including colorectal, breast, thyroid, liver, and kidney cancer. Vitamin D levels ranged from 11.8 to 25.8 ng/mL across provinces and showed a clear north-south gradient, with lower levels in southern regions receiving less sunlight. The research suggests that maintaining adequate vitamin D status may help reduce cancer mortality risk, particularly in high-latitude regions.
A major study of cancer deaths across Chile from 2002 to 2020 found that people living in areas with lower vitamin D levels had higher death rates from several types of cancer, including colorectal, breast, liver, and kidney cancer. Researchers analyzed data from 48 provinces stretching from tropical to near-Antarctic regions and discovered that vitamin D levels dropped significantly as you moved farther south. The findings suggest that vitamin D status may play an important role in cancer survival and could inform public health decisions about vitamin D supplementation and food fortification programs.
Key Statistics
A nationwide population-based study of 446,237 cancer deaths in Chile from 2002 to 2020 found that provinces with lower vitamin D concentrations had significantly higher cancer death rates for 21 of 27 cancer types analyzed, with the strongest associations for endometrial, thyroid, colorectal, liver, kidney, and larynx cancers.
Provincial mean vitamin D levels in Chile ranged from 11.8 to 25.8 ng/mL and displayed a significant north-south decreasing gradient, with lower vitamin D concentrations inversely correlated with cancer death rates across multiple cancer types.
In a 2026 ecological study spanning 48 Chilean provinces, vitamin D concentrations showed the strongest inverse associations with endometrial cancer, thyroid cancer, and colorectal cancer mortality when accounting for body mass index and tobacco use.
The Quick Take
- What they studied: Whether people living in areas with lower vitamin D levels have higher rates of dying from cancer
- Who participated: Data from 48 provinces across Chile covering 446,237 cancer deaths between 2002 and 2020, representing the entire country from tropical to near-Antarctic regions
- Key finding: Provinces with lower vitamin D concentrations had significantly higher cancer death rates for at least 21 different cancer types, with the strongest associations for endometrial, thyroid, colorectal, liver, kidney, and larynx cancers
- What it means for you: If you live in a region with less sunlight, maintaining adequate vitamin D levels through supplementation or fortified foods may help reduce cancer risk, though individual results vary and this study shows correlation, not direct causation
The Research Details
Researchers conducted what’s called an ecological study, which means they looked at large groups of people rather than individuals. They gathered information about cancer deaths across all 48 provinces in Chile from 2002 to 2020, then compared these death rates to vitamin D levels measured in a 2017 national health survey. Chile was perfect for this research because it stretches from the tropics near the equator all the way to near Antarctica, creating a natural experiment with huge differences in sunlight exposure and vitamin D levels.
The team used statistical models to analyze the data while accounting for other factors that affect cancer risk, like body weight and smoking. They looked at 27 different types of cancer to see which ones showed the strongest connections to vitamin D levels. The researchers measured vitamin D as 25(OH)D, which is the form doctors check in blood tests to determine someone’s vitamin D status.
This study design is powerful because it covers an entire country over nearly two decades, giving researchers a huge amount of real-world data. By studying provinces across such a wide range of latitudes, the researchers could see how vitamin D levels naturally vary with geography and how that relates to cancer outcomes. This approach is stronger than looking at just one city or region because it shows patterns across diverse populations and climates.
The study’s main strength is its large scale and use of national health data, which reduces bias from individual reporting. However, because this is an ecological study looking at groups rather than individuals, we cannot say for certain that low vitamin D causes higher cancer deaths. Other factors that differ between provinces could play a role. The study also relies on vitamin D measurements from 2017 being representative of the entire 2002-2020 period studied.
What the Results Show
The research revealed a clear pattern: vitamin D levels dropped as you moved from north to south across Chile, ranging from 11.8 to 25.8 ng/mL. Provinces with lower vitamin D concentrations consistently had higher death rates from multiple cancer types. The strongest associations appeared for endometrial cancer, thyroid cancer, colorectal cancer, liver cancer, kidney cancer, and larynx cancer.
Out of 27 cancer types examined, 21 showed a significant inverse relationship with vitamin D levels, meaning lower vitamin D was linked to higher death rates. This wasn’t just a coincidence for one or two cancers but a broad pattern across many different cancer types. The association was particularly strong for breast, kidney, and liver cancers when looking at the geographic patterns across provinces.
The researchers accounted for other known cancer risk factors like obesity and smoking in their analysis, and the vitamin D connection remained strong. This suggests that vitamin D status may be an independent factor affecting cancer survival rates, separate from these other well-known risks.
The study found that the relationship between vitamin D and cancer mortality was consistent across different regions of Chile, from tropical areas to those near Antarctica. This geographic consistency strengthens the argument that latitude and sunlight exposure, which determine vitamin D production, play a real role in cancer outcomes. The findings also suggest that vitamin D’s protective effect may apply to more cancer types than previously recognized by medical research.
This research confirms what earlier studies suggested about colorectal and breast cancer, showing that low vitamin D is linked to higher death rates from these cancers. However, the study provides new evidence for cancer types where the vitamin D connection was less established, including endometrial, thyroid, liver, kidney, and larynx cancers. The nationwide scope and long time period make this one of the most comprehensive studies of vitamin D and cancer mortality across multiple cancer types.
The biggest limitation is that this study looked at groups of people by province rather than tracking individuals, so we cannot prove that low vitamin D directly causes higher cancer deaths. Other differences between provinces, such as access to healthcare, screening practices, or diet, could explain some of the findings. The study also used vitamin D measurements from 2017 to represent the entire 18-year period, which may not be accurate if vitamin D levels changed over time. Additionally, the study cannot determine whether vitamin D supplementation would actually reduce cancer deaths, only that lower vitamin D is associated with higher death rates.
The Bottom Line
People living in regions with limited sunlight should consider maintaining adequate vitamin D levels through supplementation or fortified foods (moderate confidence based on this ecological evidence). Healthcare systems in high-latitude regions should evaluate vitamin D fortification programs and consider vitamin D screening as part of cancer prevention strategies (moderate confidence). Individual vitamin D supplementation decisions should be made with a healthcare provider based on personal risk factors (standard medical practice).
People living in high-latitude regions with limited sunlight exposure should pay attention to these findings. Those with personal or family histories of the cancers mentioned (colorectal, breast, thyroid, liver, kidney, endometrial, and larynx) may want to discuss vitamin D status with their doctor. Public health officials in countries with significant latitude variations should consider these findings when developing cancer prevention policies. People already diagnosed with cancer should not change their treatment plans based on this study alone but should discuss vitamin D status with their oncology team.
Vitamin D status can be improved within weeks to months through supplementation or increased sun exposure, but the effects on cancer risk reduction would take years to observe. Cancer prevention is a long-term process, and vitamin D is just one of many factors that influence risk.
Frequently Asked Questions
Does low vitamin D increase your risk of dying from cancer?
Research shows that people living in areas with lower vitamin D levels have higher cancer death rates for multiple cancer types, including colorectal, breast, and liver cancer. However, this study shows correlation, not direct causation, so low vitamin D may be one of several factors affecting cancer outcomes.
How much vitamin D do I need to reduce cancer risk?
This study did not test specific vitamin D supplementation doses. Current medical guidelines recommend 600 to 800 IU daily for most adults, though some experts suggest higher amounts. Discuss your individual vitamin D needs with your healthcare provider based on your location, age, and health status.
Does vitamin D supplementation actually prevent cancer?
This study found an association between low vitamin D and higher cancer death rates but did not test whether supplementation prevents cancer. More research is needed to determine if taking vitamin D supplements actually reduces cancer risk or improves survival.
Which cancers are most affected by vitamin D levels?
The study found the strongest associations between vitamin D and endometrial, thyroid, colorectal, liver, kidney, and larynx cancer mortality. Breast cancer also showed a strong connection. However, vitamin D appeared linked to 21 of 27 cancer types studied.
Should I get vitamin D tested if I live in a cold climate?
If you live in a high-latitude region with limited winter sunlight, discussing vitamin D testing with your doctor is reasonable, especially if you have risk factors for the cancers mentioned in this research. A simple blood test can measure your vitamin D status.
Want to Apply This Research?
- Track your vitamin D supplementation intake (dose and frequency) and correlate it with energy levels and seasonal mood changes. Record your location’s latitude and average daily sunlight exposure to understand your natural vitamin D production potential.
- Set a daily reminder to take vitamin D supplements if you live above 35 degrees latitude or during winter months. Log your sun exposure time (15-30 minutes daily when possible) and track any dietary sources of vitamin D like fortified milk, fatty fish, or egg yolks.
- Request vitamin D blood tests (25(OH)D) twice yearly, ideally in spring and fall, to monitor your status across seasons. Track cancer screening appointments and maintain records of any family history of the cancers mentioned in this research to identify personal risk factors.
This research shows an association between vitamin D levels and cancer death rates but does not prove that low vitamin D causes cancer deaths. This study was conducted at the population level and cannot determine individual risk. Vitamin D supplementation decisions should be made with your healthcare provider based on your personal health status, location, and risk factors. This information is not a substitute for professional medical advice, diagnosis, or treatment. Do not change cancer treatment or screening plans based on this research alone. If you have concerns about cancer risk or vitamin D status, consult with your doctor or oncologist.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.